Vivione Biosciences Inc. announced the termination of Ted Moskal as President of Vivione and its operating subsidiary, Vivione Biosciences, LLC. Day-to-day responsibilities with the FDA will be assumed by Chief Medical Officer, Dr. Matthew Gombrich.
1st Jan change | Capi. | |
---|---|---|
+16.44% | 3.1B | |
+12.82% | 1.77B | |
-11.54% | 1.21B | |
+17.80% | 790M | |
+9.81% | 673M | |
+28.17% | 570M | |
-4.17% | 508M | |
+34.47% | 502M | |
+80.62% | 342M |